This article has been updated from a previous version to include additional information about the partnership.
Avecia is a GMP oligo manufacturer based in
The companies said that the alliance will speed the manufacture of oligos for drug discovery, development, and commercialization, and will offer an option for drugmakers "looking to minimize the challenges and risks associated with transitioning from a research-grade vendor to an oligonucleotide development service and manufacturing company."
Benefits of the common technology platform include "regulatory simplicity, cost control, time savings and risk minimization," the companies said.